Stocks NEOV Financial statements
Financial statementsNeoVolta Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data NeoVolta Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Revenue | 4.82 | 4.47 | 3.46 | 2.65 | 8.43 | 13.3 |
| Cost of revenue | 4.18 | 3.81 | 2.77 | 2.13 | 6.92 | 11.2 |
| Gross profit | 0.65 | 0.67 | 0.69 | 0.51 | 1.51 | 2.14 |
| Research and development | 0.04 | 0.07 | 0.03 | 0.02 | 0.16 | 1.56 |
| General and administrative | 8.26 | 6.35 | 3.29 | 2.83 | 6.07 | 18.3 |
| Operating expenses | 8.3 | 6.42 | 3.32 | 2.85 | 6.22 | 20.3 |
| Operating income | -7.65 | -5.76 | -2.64 | -2.34 | -4.72 | -18.1 |
| Interest expense | 0.02 | 0.05 | 0 | 0 | 0.32 | 0.67 |
| Interest income | 0 | 0.14 | ||||
| Other non-operating income | 0.01 | -0.05 | -0 | 0.03 | -0.32 | -3.33 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -7.65 | -5.8 | -2.64 | -2.3 | -5.03 | -21.5 |
| EBITDA | -4.72 | -17.7 | ||||
| EPS, basic | -0.43 | -0.28 | -0.08 | -0.07 | -0.15 | -0.55 |
| EPS, diluted | -0.43 | -0.28 | -0.08 | -0.07 | -0.15 | -0.55 |
| Shares, basic (weighted) | 17.9 | 20.6 | 32 | 33.2 | 33.6 | 39.3 |
| Shares, diluted (weighted) | 17.9 | 20.6 | 32 | 33.2 | 33.6 | 39.3 |
Balance sheet
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 0.43 | 0.33 | 2 | 0.99 | 0.79 | 22.2 |
| Receivables | 1.13 | 1.32 | 1.83 | 1.81 | 2.98 | 2.95 |
| Inventory | 1.66 | 2.24 | 2.58 | 1.79 | 2.14 | 2.13 |
| Other current assets | 0.05 | 0.24 | 0.1 | 0.08 | 0 | 0.27 |
| Total current assets | 3.26 | 4.13 | 6.51 | 4.66 | 6.66 | 32.8 |
| Property, plant and equipment | 0 | 9.93 | ||||
| Lease right-of-use assets | 0 | 0.14 | 8.08 | |||
| Intangible assets | 0 | 1.06 | ||||
| Other non-current assets | 0 | 1.63 | ||||
| Total assets | 3.26 | 4.13 | 6.51 | 4.66 | 6.81 | 53.6 |
| Accounts payable | 0.05 | 0.21 | 0 | 0.01 | 0.69 | |
| Accrued liabilities | 0.08 | 1.04 | ||||
| Short-term debt | 0 | 2.6 | 1.12 | |||
| Total current liabilities | 0.09 | 1.45 | 0.04 | 0.06 | 3.51 | 6.68 |
| Lease liabilities | 0 | 7.39 | ||||
| Total liabilities | 0.11 | 1.51 | 0.04 | 0.06 | 3.9 | 14.1 |
| Total debt | 1.12 | |||||
| Paid-in capital | 13.2 | 18.4 | 24.9 | 25.3 | 28.7 | 86.8 |
| Retained earnings | -10 | -15.8 | -18.4 | -20.7 | -25.8 | -47.2 |
| Shareholders' equity | 3.15 | 2.62 | 6.47 | 4.6 | 2.91 | 39.6 |
| Total equity | 3.15 | 2.62 | 6.47 | 4.6 | 2.91 | 39.6 |
| Total liabilities and equity | 3.26 | 4.13 | 6.51 | 4.66 | 6.81 | 53.6 |
| Shares outstanding | 19.6 | 22 | 33.2 | 33.2 | 34.1 | 58.3 |
Cash flow statement
| FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|
| Net income | -7.65 | -5.8 | -2.64 | -2.3 | -5.03 | -21.5 |
| Depreciation and amortization | 0 | 0.41 | ||||
| Stock-based compensation | 7.44 | 5.31 | 1.53 | 0.43 | 2.1 | 4.96 |
| Change in receivables | -0.74 | -0.19 | -1 | -0.52 | -1.63 | -3.01 |
| Change in inventory | -0.11 | -0.58 | -0.34 | 0.7 | 0.04 | -0.83 |
| Change in payables | 0.05 | 0.15 | -0.21 | 0.01 | 0.68 | 0.5 |
| Cash from operations | -0.88 | -1.16 | -2.11 | -1.02 | -4.43 | -15.2 |
| Cash from investing | 0 | -8.63 | ||||
| Cash from financing | 0 | 1.07 | 3.78 | 0 | 4.23 | 48.4 |
| Net change in cash | -0.88 | -0.1 | 1.67 | -1.02 | -0.19 | 24.6 |
| Interest paid | 0 | 0 | 0 | 0 | 0.14 | 0.86 |
| Income taxes paid | 0 | 0 | 0 | 0 | 0 | 0 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 16.0% | Gross profit / revenue. |
| Operating margin | -136.1% | Operating income / revenue. |
| EBITDA margin | -133.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Net margin | -161.0% | Net income / revenue. |
| Operating cash flow margin | -113.9% | Cash from operations / revenue. |
| Return on equity (ROE) | -101.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -71.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | -147.1% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 11.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 37.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| D&A / revenue | 3.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 58.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 56.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 22.5% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 41.9% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 45.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 27.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 1,260.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 82.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 65.9% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 688.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 102.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 75.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 17.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 7.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 17.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 4.92x | Current assets / current liabilities. |
| Quick ratio | 3.77x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 3.32x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 26.2% | Total liabilities / total assets. |
| Interest coverage | -27.2x | Operating income / interest expense. |
| Working capital | $26.2M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 2.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $38.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.44x | Revenue / average total assets. |
| Fixed asset turnover | 2.69x | Revenue / average property, plant and equipment. |
| Inventory turnover | 5.24x | Cost of revenue / average inventory. |
| Days inventory | 70 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 4.50x | Revenue / average receivables. |
| Days sales outstanding | 81 days | 365 x average receivables / revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.55 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.55 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $0.34 | Revenue / diluted weighted shares. |
| Operating cash flow per share | -$0.39 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.68 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.66 | Tangible book value / shares outstanding. |
| Cash per share | $0.38 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $128.9M | Share price x shares outstanding. |
| Enterprise value | $106.7M | Market cap + total debt - cash - short-term investments. |
| P/S | 9.67x | Market cap / revenue. |
| P/B | 3.26x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.35x | Market cap / tangible book value, when positive. |
| EV/Sales | 8.00x | Enterprise value / revenue. |
| Earnings yield | -16.7% | Net income / market cap (the inverse of P/E). |
What was NeoVolta Inc.'s revenue in fiscal 2026?
NeoVolta Inc. reported revenue of $13.3M for fiscal 2026, 58.2% higher than the year before.
Was NeoVolta Inc. profitable in fiscal 2026?
No. It reported a net loss of $21.5M.